Active Ingredient(s):Pirbuterol FDA Approved: * December 30, 1986 Pharm Company: *3M Category:Asthma
Pirbuterol (trade name Maxair) is a short-acting β2 adrenoreceptor agonist with bronchodilating action used in the treatment of asthma, available (as pirbuterol acetate) as a breath-activated metered-dose inhaler.
It was patented in 1971 and came into medical use in 1983.
1 Medical use
2 Mode of action
4 Adverse effects
6 External links
Pirbuterol is used in asthma for reversal of acute bronchospasm, and also ...
* May have multiple approval dates, manufacturers, or labelers.